Efficacy of combination therapy of amphotericin and posaconazole in treatment of mucormycosis
Background: Mucormycosis is an opportunistic systemic fungal infection which is debilitating caused by order Mucorales. The standard management of mucormycosis consists of aggressive debridement of the infected tissue and parenteral anti-fungal therapy with Amphotericin B. Liposomal amphotericin B i...
Saved in:
Main Authors: | Sridhara S (Author), Ramesh Sanappa (Author), Nandini P (Author), Gayatri Jayan (Author), Gangadhara KS (Author) |
---|---|
Format: | Book |
Published: |
Creative Pharma Assent,
2023-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mucormycosis in a Severe Trauma Patient Treated with a Combination of Systemic Posaconazole and Topical Amphotericin B-Case Report
by: Filip Keller, et al.
Published: (2023) -
Management of rhinomaxillary mucormycosis with Posaconazole in immunocompetent patients
by: Sachin Rai, et al.
Published: (2016) -
Posaconazole as single or adjunctive antifungal in mucormycosis of the maxilla: systematic review and meta-analysis
by: Pardiwala Arwa, et al.
Published: (2023) -
Pharmacokinetic/pharmacodynamic study of posaconazole delayed-release tablet in a patient with coexisting invasive aspergillosis and mucormycosis
by: Leelawattanachai P, et al.
Published: (2019) -
A brief profile of laryngeal lesions undergoing microlaryngeal surgery by telescopic method
by: K S Gangadhara, et al.
Published: (2023)